Racial/ethnic differences in the clinical presentation and survival of breast cancer by subtype
Breast cancer (BC) affects racial and ethnic groups differently, leading to disparities in clinical presentation and outcomes. It is unclear how Hispanic ethnicity affects BC outcomes based on geographic location and proximity to the United States (U.S.)/Mexico border. We hypothesized that the impact of race/ethnicity on BC outcomes depends on geographic location and country of origin within each BC subtype
Racial, ethnic differences seen in breast cancer treatment declination
“Our findings highlight racial and ethnic disparities in declination of treatment recommendations and overall survival, suggesting the need for equity-focused interventions,” the authors write.
Proposed lung cancer screening guideline could eliminate racial disparities, allow for early detection
The U.S. Preventative Services Task Force currently recommends annual lung cancerscreening for adults aged 50 to 80, who have at least a 20-pack-year smoking history (one pack year is the equivalent of smoking an average of 20 cigarettes per day for a year), and who either currently smoke or quit smoking within the last 15 years.
US launches campaign to address racial disparities in lung cancer biomarker testing
In the study by Bruno and colleagues, 23,488 patients diagnosed from 2017 to 2020 with advanced/metastatic NSCLC, metastatic colorectal cancer (CRC), or metastatic breast cancer were obtained from a real-world database (Flatiron Health Electronic Health Record) to examine racial disparities in biomarker testing and clinical trial participation.
Top in women’s health: Racial disparities in cancer detection, early death rates
Rates of early death from gynecologic cancers were higher among Black women compared with women of other races and ethnicities, recent data show. The largest disparity in early death was for tubo-ovarian cancer, with a 14.5% rate for Black women vs. a 6.4% rate for Asian women.
